Breast tumor | Ovarian tumor | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Case # | BRCA status | Age at diagnosis | Stage | Local treatment | Systemic treatment | Age at diagnosis | Time interval from BC (months) | FIGO stage | Metastatic site | Outcome |
1 | ND | 45 | III | M | CT-T | 48 | 34 | IV | Liver | DOD |
2 | ND | 48 | III | M | CT | 48 | 73* | IV | Liver | DOD |
3 | ND | 45 | III | BCS | CT-T | 57 | 150 | IV | Bone, liver | DOD |
4 | ND | 59 | I | BCS | No | 70 | 130 | IV | Peritoneal carcinomatosis, axillary LN | DOD |
5 | ND | 57 | III | M | T | 58 | 20 | IIIc | NA | DOD |
6 | ND | 49 | III | M | CT-T | 52 | 33 | IIIc | NA | DOD |
7 | BRCA2 m | 66 | I | BCS | CT | 67 | 19 | Ic | NA | NED |
8 | BRCA1 wt, BRCA2 uk | 46 | III | BCS | CT-T | 46 | 0 | IIa | NA | DOD |
9 | ND | 34 | III | M | CT-T | 45 | 133 | IV | Peritoneal carcinomatosis, supraclavicular LN, brain | SD |
10 | ND | 47 | III | M | T | 54 | 83 | IIIc | NA | NED |
11 | BRCA1 m | 69 | III | M | CT | 71 | 24 | IIa | NA | DOD |
12 | Familial history ¤ | 47 | III | M | CT-T | 54 | 79 | IIIc | NA | DOD |
13 | ND | 50 | I | BCS | No | 57 | 87 | IIc | NA | NED |
14 | ND | 57 | II | BCS | T | 64 | 82 | IIc | NA | NED |
15 | BRCA1 wt, BRCA2 wt | 32 | III | M | CT | 38 | 74 | IV | Pleura | DOD |
16 | ND | 48 | II | BCS | CT | 49 | 18 | IIIc | NA | DOD |